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Obesity and hyperiension frequently develop after heart trans
.
plantation . The cardiac adaptation m ohesny and hyperersinn
was studied by determining hemodynamic and echaardiographic
indexes in 10 obese hypertensive patient (body gno index
=_27 .8 kill." in coon or x27.3 t/ghar in women) matched hp mean
arterial pressure, age and gender with 10 nonobese hypertenslve
patients I year after cardiac transplantation . Cardiac output was
30'7 greater (p < 0 .02) and systemic vascular resistance 25%
lower (p < 0.011 in the obese than in the nunubese patients. Right
verricular systolic and pulmonary artery systolic, diastolic and
mean pressures were also significantly higher ip - 9 .95) in the
obese patients . Left ventricular end-diastolic diameter was 25%
greater (p < 0.05), left ventricular mass 28% greater (p ¢ 0 .02(
Obesity and systemic arterial hypertension are two condi-
tions that have been directly related
. Thus, the incidence of
hypeneusit o in an obese population is greater than that in a
nonobese population (11. Furthermore, epidemiologic stud-
ies (I-4) have shown that obesity and hypertension are
independent risk factors for congestive heart failure and
other causes of cardiovascular morbidity and mortality . In
the general population the heart adapts to obesity and
hypertension by the development of eccentric left ventricu-
lar hypertrophy (that is
. left ventricular dilation and an
increase in left ventricular mass) fl)-
Heart transplantation has became an accepted therapy
for end-stage heart failure, particularly since cyclospotine
was introduced as an immunosapprcssive agent (51. How-
ever, patients treated with cyclosporine have a significantly
increased prevalence of hypertension after transplantation
compared with patients treated with azathiciprine and pred-
nisene (6-91. In addition, after heart €ransplamation patients
frequently gain weight, often to obesity (101
. This weight
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and left ventricular enddiaMdic vulame 20% higher (p <
0 .01) In
the obese subjects . Left ventricular ejectoo Iranians was sigat0 .
canny lower in the Obese than in the nonobese subjects (34% vs.
51%,0,0
.051.
These results indicate That Ike cardiac adaptation to obesity
and hypertemion after
ban transplantation consists of left ven,
tricolor dilation and an increase in left ventricular mass associated
with an increased cardiac output and lower peripheral vascular
resistance . These adapt,ve changes that occur in obese hypnlea-
sive patients after heart transplaotathm might increase the hmg-
term elk of graft failure, as suggested by O+er lower left
ventricular ejection fraction I year after transplantation
.
(J Am Coo Cardiol 1992,19155-9)
gain is certainly caused partly by an increase in appetite due
to the use of prednisone in many immunosuppressive regi-
mcns . Thus, partly in relation to their immunosuppressive
therapy . many heart transplant patients develop both arterial
hypertension and obesity .
The purpose of the present study was to evaluate she
cardiac adaptation to obesity and hypertension after heart
transplantation by reviewing systemic hemedynamics,
echocardiograms
and ventricular function in nonobese and
obese hypertensive ortholopie heart transplant recipients I
year after traaspiantation .
Methods
Patient selecoeo. The study group consisted of 20 hyper-
tensive patients who were evaluated I year after orthotopic
hear transplantation. Clinical evaluation and definition of
hypertension (diastolic pressure >90 mm Hg measured by
cuff method) followed established guidelines (11). Antihy-
pertensive agents prescribed for these patients consisted of
either a calcium channel blocking agent, an angiotensin-
converting enzyme inhibitor or a central acting agent
. Body
mass index was calculated as weight in kgfheight in m z and
patients were classified into obese and nonobese groups by
using partition values for body mass index (?27 .8 kgfm2 for
men and X27
.3 kg/mz for women) representing the 85th
percentile of values according to the National Health and
Nutrition Evaluation Survey 11 (12).
Ten nonobese and 10 obese hypertensive patients who
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were matched by mean artery) pressur , age and gender Table 1. Baseline Characteristics of 20 Paneots Undergoing
formed the study group. Most patients were receiving im-
munosoppressive therapy with cyclosporine, prednisone and
azathioprine. Two patients in the *best group and three
patients in the nonobese group were receiving cyclesporine
and prednisone only . No patient had acute allograft rejection
or angiographic evidence of allograft arterinpathy at the time
of the study-
Hemodynamic evaluation. The hemodynamic values
were measured at the time of the endomyocardial biopsy
as previously reported 113) . Right heart pressures were
measured with use of a balloon-tipped pulmonary artery
catheter . Cardiac output was measured in triplicate by
the thermodilution method ; the average of the three values
sins recorded . Mean arterial pressure was calculated
from cuN'bleod pressure readings by adding one third of the
pulse pressure to the diastolic blood pressure . Systemic
vascular resistance was calculated with the following
formula;
Mean arterial pressure - Mean right atria) pressure
	-- -- x
go
.
Cardiac output
Definition and diagnosis of rejection . The diagnosis of
acute rejection was made on the basis of the histologic
changes observed on endomyocardial biopsy sample . (13) .
Briefly, rejection was graded as mild, moderate: or severe
according '.o the degree of the lymphncytic infiltrate and
myocyte mrcrosis (13) .
Echocardiographic evaluation . Echocardiography was
perforated after the right heart catheterization and endes-
myocardial biopsy. Echocardiographic measurements were
made according to the iceommendations of t2a American
Society of Echocardiography (14) . Left ventricular end-
diastolic diarnnter and the thickness of the interventricular
septum and left ventricular posterior wall were measured at
the end of diastole, as defined by the onset of the QRS
complex . Left ventricular mass was calculated with use of
the formula of Troy et al . (15). Left ventricular volumes were
estimated by the method of Teichholz et al . (16) and peak
systolic stress was measured by the noninvasive method of
Wilson er Id. (17).
Ventrieolar runlet;nn; Right and left ventricular function
were evaluated with use of radionuclide angiographic tech-
niques, as previously described (18) .
Renal function
. Serum creatinine and creatininc clear-
ance were measured in all study patients 1 year after
orlitotopic heart transplantation and were used as indicators
of renal function.
Statistical analysis, Data are reported as mean values
SD. Unpaired Student's r tests were used to compare
clinical, hemodynamic, echocardiographic and ventricular
function variables of nonobese and obese hypertensive or-
tholopic heart transplant recipients.
'There went ou signilcunr diiferenxs between goups in the baseline
characrencsscunr d
Results
Patient characteristics (Tables 1 and 2)
. At the time of
heart transplantation there was no difference in baseline
weight. mean arterial pressure and ejection fraction between
the two groups (Table 1) . The nonobese and obese hyper-
tensive patient groups at I year after heart transplantaton
were matched by mean arterial pressure, age and gender
it .'
the two groups also did not differ with respect to height . By'
design of the study, weight, body surface area and body
mass index were sign'ifirarsay ^realer in the obese peyrtrs .
Renal function and the number of rejection episodes per
patient were similar in oonobesc and obese patients (Table
2) .
Hemodynaoic indexes (Tables 2 and 3
) .
At 1 You after
orthetepic heart transplantation, obese patients in compari-
son with nonobese patients were characterised by a signifi-
cantly higher cardiac output (30%. p < 0.02) and lower
systeric vascular resistance (25%, p < 0,01) at the same
level of mean arterial pressure- In addition, right ventricular
systolic pressure and pulmonary artery systolic, diastolic
and mean pressures were significantly higher in the obese
patients (p < 0.05) . At I year after orthelopic heart trans-
plantation . obese patients, when compared with nonobese
patients with similar mean systolic arterial pressure, had a
significantly higher cardiac output (6 ± 1 vs . 4.6 ± 0 .8
tiletsrmin ; p < 0
.02) and lower systemic vascular resistance
(1,413 ^ 18 vs . 1,881 -' 19 dynes/s per cm - ' ; p < 0.01 ;
(Table 3) . Cardiac output correlated significantly with body
mass index (r = O .6t : n < 0 .004) .
Table 2. Clinical Characteristics of 20 Patients 1 Year After
Heart Transplantation
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Table 3. Postoperative Hemodynamic Values I Year After
	
an increased cardiac erttpur, left ventricular dilation and a
lower ejection fraction at I year after transplantation .
Hypertension after heart transplantation . Arterial hyper-
tension is a serious and frequent complication of cyclospo-
rine therapy in heart transplant recipients (7) . In orthotopic
heart transplant recipients, hypertension is detected as early
as the 1st postoperative week (19), is frequently established
by 50 days postoperatively (7) and has been reported to
occur in 38% to 92% of such recipients (20). The etiology of
cyclosporine-induced hypertension is not clear but several
factors may contribute to is development. Patients with
hypertension after heart transplantation have an elevated
systemic vascular resistance and a normal cardiac output,
suggesting an alteration of vascular compliance (20) . How-
ever, urinary calecholamines, plasma renin activity and
plasma aldustcrone and angiotensiitogen levels have been
found to be normal (6,20 .21). An association between hyper-
tension after transplantation, renal insufficiency and in-
creased plasma volume has been reported (7) but this finding
has not been confirmed in other studies (9). Because patients
with cyclospodne-induced hypertension do rut have a noc-
turnal decrease in blood pressure, it has also been suggested
that abnormal central nervous system control of blood
pressure may play a role in the development of hypertension
after transplantation
(7.2)-
TTie :,- eight gain induced by cardroateroids may also
contribute to the development of increased blood pressure
after orthotopic heart transplantation . The results of some
previous studies (23) suggest that the blood pressure de-
creases and fewer anti hypertensive medications are required
in patieuts who can be withdrawn from corticosteroid ther-
apy . Moreovcr, patients who gain the least weight after
cardiac transplantation are more likely to remain normoten-
sivc (9).
Previous studies have reported an abnormal left ventric-
ular cud-diastolic pressure, a lower ejection fraction (24) and
the development of cuuceninc left ventricular hypertrophy
1251 in hypertensive patients I year after orhoropic heart
tansplantation .
Role of obesity. Obesity, as defined by an excess of frady
fat, has been shown to increase total body oxygen demands .
To meet this demand, cardiac output, blood volume and
preload increase in obese patients regardless of the level of
arterial pressure (26-301 . [o addition, obesity may also lead
to altered systolic and diastolic performance (31-33)
.
The increased cardiac output observed in our obese
recipients 1 year after orthotopic heart transplantation is it .
accord with previous findings (26-30) . Because we did not
measure total blood volume, the mechanism of the increased
cardiac output remains speculative . However, it seems
likely that in these patients the increased left ventricular
end-diastulic volume is produced by an increase in preload
(26,27). Heart rate and stroke volume were also somewhat
higher in obese patients, thus contributing to the significant
increase in cardiac output .
In the general population, arterial hypertension detected
Heart Transplantation
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Myocardial structure and function (Table 4) . As mea-
sured by echocardiography and radionuclide angiegraphy at
I year after orthotopic heart transplantation . obese patients
had a significantly greater left venricular end-diastulic di-
ameter (25% ; 6.0 a 0.1 vs . 4.8
.
0.3 em ; p < 0 .05) and
end-diastolic volume (20% : 135 ± 10 vs . 106 a 5 ml
; p
0
.011 and a greater left ventricular mass
(28`70 ; 312 `- 7 '.
241 ± 7 g : p e- 0 .22) and Itft ventric<1ar :nasslhcight ratio
(27% ; 181 ± 3 vs . 145 ± 3 elm) at the same level of arterial
pressure Wig . I) . Left ventricular mass correlated signifi-
cantly with body m ::
;
index Cr = 0.6; p < 0.0041
. There were
no differences in posterior wall or septal thickness . Peak
systolic stress, although higher in the obese group, did not
achieve statistical significance (fable 4)
. The left ventricular
ejection fraction was significantly lower in the obese patients
(33% ; 34 ! 4 vs . 51 a 3% ; p < 0.05) .
Discussion
The results of our study indicate that the cardiac adapta-
tion to hypertension after transplantation in cyclosporine-
treated patients differs in nonnbese and obese patients .
Compared with nonnbese hypertensive orthotopic heart
transplant recipients, obese heart transplant recipients have
Table 4. Echocardiographic Indexes of Myocardial Structure and
Radionuclide Ventnculographic Indexes of Cardiac Function I
Year After Sean Transplantation
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in nonobese patients is characterized by a high systemic
vascular resistance, which may make these patients more
prone to end-organ damage (26) . Because by study design
mean arterial pressure was equal in obese and nonobese
patients, a higher cardiac output is associated with a lower
systemic vascular resistance . Therefore, for any given level
of arterial pressure, systemic vascular resistance was lower
in the obese than the nonobese transplant patients, How-
ever, no conclusions can be reached as to whether obese
patients are at lower risk than nonobese patients for devel-
oping systemic sascular disease (that is, end-organ damage)
because of their lower vascular resistance .
Role of increased left
ventricular
mass. Epidemiologic
studies have shown that weight, body mass indes and
arterial pressure are major determinants
of
left venlrcular
mass (34-37) . Furthermore, the results of recent studies
suggest that increased left ventricular mass is an indepen-
dent risk factor for cardiovascular events 136,37) . In
nonobese individuals in the general population . the adapta-
tion to arterial hypertension consists of ventricular hyper-
trophy without chamber dilation, that is, coaxidric left
ventricular hypertrophy 11) . In contrast. in obese patients
the adaptation to hypertension includes the development of
hypertrophy and vent icular dilation or eccentric left ven-
trieutar hypertrophy 11,38) . Because of the increased preload
and the concomitant systolic and diastolic abnormalities,
patients who are both obese and hyperlensive may be at
higher risk for developing premature congestive heart fail-
ure, ventricular arrhythmias (391 and other cardiovascular
complications (1) . The cardiac adaptation to obesity and
hypertension after heart transplantation was characterized
by an increased left ventricular mass and left ventricular
end-diastolic diameter (eccentric left ventricular hypertro-
phy) . In fact, body mass index strongly correlated with left
ventricular mass in this study group. These findings are
similar to those of obese patients with essential hyperten-
sion.
Although body surface area has been used as an inn?ex of
obesity . i
t has hero shown to underestimate hemndyma
.mic
variables
and
measurements of left ventricular struct ire.
Therefore, the use of height or ideal body surface area nosy
provide a better index of body habitus (1434).
EJeclion fraction
. The mechanism of decreased left ven-
tricular ejection fraction in obese patients after heart trans-
plantation remains speculative . An increase in the numberof
rejection episodes can be postulated ; however, there was no
difference between the groups jn our study . Therefore, either
the increase in systolic stress not associated with an appm-
ptiale increase in wall thickness or an inuinsic decrease in
ventricular contractility can account for the lower ejection
fraction.
Conclusions . The present study shows that after ortho-
topic bea(itansplantatioa obese hypertensive patients have
a higher cardiac output and lower systemic vascular resis-
tance at any given level of mean arterial pressure than do
nonobese hypertensive patients . After orthotopic heart
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transplantation. cardiac adaptation to both obesity and hy-
pertension consists of
eccentric left ventricular hypertrophy
and impaired sysnulic performance . The presence of these
abnormalities indicates that obesity superimposed on hyper-
tension after transplantation may increase the risk of al-
lograft failure
. Studies on larger numbers of patients fol-
lowed for longer periods of
time are needed to confirm our
results
. However, because obese hypertensive orthotepic
heart transplant recipients are at greater risk of heart ai-
lograft failure, weight loss and control
of hypertension
should be strongly recommended.
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